scholarly journals Biopsy findings in giant cell arteritis: relationship to baseline factors and corticosteroid treatment

2013 ◽  
Vol 42 (4) ◽  
pp. 331-332 ◽  
Author(s):  
K Jakobsson ◽  
L Jacobsson ◽  
K Warrington ◽  
EL Matteson ◽  
C Turesson
Keyword(s):  
Giant Cell Arteritis ◽  
Giant Cell ◽  
Corticosteroid Treatment ◽  
Baseline Factors

Osteoporosis after long-term corticosteroid treatment of giant cell arteritis

1990 ◽  
Vol 227 (6) ◽  
pp. 391-395 ◽  
Author(s):  
R. ANDERSSON ◽  
Å. RUNDGREN ◽  
K. ROSENGREN ◽  
B.-Å. BENGTSSON ◽  
B.-E. MALMVALL ◽  
...  
Keyword(s):  
Giant Cell Arteritis ◽  
Giant Cell ◽  
Corticosteroid Treatment

Arteritic Anterior Ischemic Optic Neuropathy

2011 ◽  
pp. 11-15
Author(s):  
Matthew J. Thurtell ◽  
Robert L. Tomsak ◽  
Robert B. Daroff
Keyword(s):  
Giant Cell Arteritis ◽  
Giant Cell ◽  
Optic Neuropathy ◽  
Corticosteroid Treatment ◽  
Anterior Ischemic Optic Neuropathy ◽  
Medical Emergency ◽  
Ischemic Optic Neuropathy ◽  
Fellow Eye ◽  
Timely Fashion ◽  
Eye Involvement

Arteritic anterior ischemic optic neuropathy occurs in the setting of giant cell arteritis and is a medical emergency, because there is a high risk of fellow eye involvement if corticosteroid treatment is not initiated in a timely fashion. In this chapter, we review the clinical features of arteritic anterior ischemic optic neuropathy. We also discuss the evaluation and treatment of patients with suspected giant cell arteritis.

High blood levels of chromogranin A in giant cell arteritis identify patients refractory to corticosteroid treatment

2009 ◽  
Vol 68 (2) ◽  
pp. 293-295 ◽  
Author(s):  
G Di Comite ◽  
P Previtali ◽  
C M Rossi ◽  
G Dell’Antonio ◽  
P Rovere-Querini ◽  
...  
Keyword(s):  
Giant Cell Arteritis ◽  
Giant Cell ◽  
Chromogranin A ◽  
Corticosteroid Treatment ◽  
Blood Levels

scholarly journals Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis

Rheumatology ◽  
2012 ◽  
Vol 51 (11) ◽  
pp. 1999-2003 ◽  
Author(s):  
C. Hauenstein ◽  
M. Reinhard ◽  
J. Geiger ◽  
M. Markl ◽  
A. Hetzel ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Giant Cell Arteritis ◽  
Giant Cell ◽  
Corticosteroid Treatment ◽  
Resonance Imaging

Persistent Giant Cell Arteritis Despite Corticosteroid Treatment

1994 ◽  
Vol 69 (11) ◽  
pp. 1060-1061 ◽  
Author(s):  
JONATHAN M. EVANS ◽  
KENNETH P. BATTS ◽  
GENE G. HUNDER
Keyword(s):  
Giant Cell Arteritis ◽  
Giant Cell ◽  
Corticosteroid Treatment

Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment

1999 ◽  
Vol 127 (1) ◽  
pp. 102-104 ◽  
Author(s):  
Jeong-Min Hwang ◽  
Christopher A. Girkin ◽  
Julian D. Perry ◽  
James C. Lai ◽  
Neil R. Miller ◽  
...  
Keyword(s):  
Giant Cell Arteritis ◽  
Giant Cell ◽  
Corticosteroid Treatment ◽  
Ocular Ischemic Syndrome ◽  
Ischemic Syndrome

scholarly journals Steroid Induced Central Serous Chorioretinopathy in Giant Cell Arteritis

2013 ◽  
Vol 2013 ◽  
pp. 1-3
Author(s):  
Andre Grixti ◽  
Vineeth Kumar
Keyword(s):  
Differential Diagnosis ◽  
Giant Cell Arteritis ◽  
Giant Cell ◽  
Central Serous Chorioretinopathy ◽  
Visual Loss ◽  
Corticosteroid Treatment ◽  
High Dose ◽  
Cataract Formation ◽  
Ocular Side ◽  
Systemic Corticosteroids

Giant cell arteritis (GCA) is an ophthalmic emergency which requires early diagnosis and treatment with high dose systemic corticosteroids in order to prevent permanent visual loss. However, systemic corticosteroids have significant ocular side effects including cataract formation, raised intraocular pressure, and less commonly, central serous chorioretinopathy (CSCR). We report a case of visual loss secondary to CSCR complicating corticosteroid therapy in GCA. When assessing patients with systemic conditions such as GCA or other vasculitic process, who complain of visual loss which is getting worse on corticosteroid treatment, clinicians should consider other causes such as CSCR as part of the differential diagnosis. Extra caution should be exercised in such cases as increasing the dose of corticosteroids might aggravate CSCR resulting in further visual loss.

PREVENTION OF BLINDNESS IN GIANT CELL ARTERITIS BY CORTICOSTEROID TREATMENT

Rheumatology ◽  
1992 ◽  
Vol 31 (2) ◽  
pp. 103-105 ◽  
Author(s):  
A. B. MYLES ◽  
T. PERERA ◽  
M. G. RIDLEY
Keyword(s):  
Giant Cell Arteritis ◽  
Giant Cell ◽  
Corticosteroid Treatment
Sign in / Sign up

Export Citation Format

Share Document